Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2001, p. 314-319, Vol. 8, No. 2
Department of Gastrointestinal
Infections1 and Department of
Epidemiology Research,2 Statens Serum
Institut, DK-2300 Copenhagen S, Denmark
Received 14 July 2000/Returned for modification 19 October
2000/Accepted 11 December 2000
An enzyme-linked immunosorbent assay (ELISA) was adapted to measure
immunoglobulin G (IgG), IgM, and IgA classes of human serum antibody to
Campylobacter jejuni and Campylobacter coli. Heat-stable antigen, a combination of C. jejuni serotype
O:1,44 and O:53 in the ratio 1:1, was used as a coating antigen in the ELISA test. A total of 631 sera from 210 patients with verified Campylobacter enteritis were examined at various intervals
after infection, and a control group of 164 sera were tested to
determine the cut-off for negative results. With a 90th
percentile of specificity, IgG, IgM, and IgA showed a sensitivity of
71, 60, and 80%, respectively. By combining all three antibody
classes, the sensitivity was 92% within 35 days after infection,
whereas within 90 days after infection, a combined sensitivity of 90%
was found (IgG 68%, IgM 52%, and IgA 76%). At follow-up of the
patients, IgG antibodies were elevated 4.5 months after infection but
exhibited a large degree of variation in antibody decay profiles. IgA
and IgM antibodies were elevated during the acute phase of infection
(up to 2 months from onset of infection). The antibody response did not
depend on Campylobacter species or C. jejuni
serotype, with the important exception of response to C. jejuni O:19, the serotype most frequently associated with
Guillain-Barré syndrome. All of the patients infected with this
serotype had higher levels of both IgM (P = 0.006) and
IgA (P = 0.06) compared with other C. jejuni and C. coli serotypes.
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.314-319.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antibody Responses to Campylobacter
Infections Determined by an Enzyme-Linked Immunosorbent Assay:
2-Year Follow-Up Study of 210 Patients
*
Corresponding author. Mailing address: Department
of Gastrointestinal Infections, Division of Diagnostics, Statens
Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark.
Phone: 45 3268 3745. Fax: 45 3268 8238. E-mail: kak{at}ssi.dk.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |